Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature review
Braz. j. infect. dis
;
18(1): 110-113, Jan-Feb/2014. tab, graf
Article
in English
| LILACS
| ID: lil-703056
ABSTRACT
Pegylated interferon alpha (Peg IFN-α) in combination with ribavirin is the backbone of treatment in chronic hepatitis C (CHC). Cardiotoxicity due to interferon therapy is rare. The most frequent cardiovascular complications are arrhythmias and ischemic manifestations. Cardiomyopathy is extremely rare but can be life threatening. We present the case of a 41-year-old female patient with CHC in whom Peg IFN-α induced dilated cardiomyopathy and hypothyroidism. Chest radiography showed an enlarged and globular cardiac silhouette and pulmonary congestion. Echocardiography showed decreased left ventricular systolic function with an ejection fraction of 32% and fractional shortening of 15%. Cardiomyopathy had a complete remission after cessation of antiviral therapy with short-term heart failure medications and supportive care. Then we review the current literature about interferon induced cardiomyopathy in patients with HCV infection, as well as share our clinical experience in diagnosing and managing this rare complication.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Antiviral Agents
/
Ribavirin
/
Cardiomyopathy, Dilated
/
Interferon-alpha
/
Hypothyroidism
Type of study:
Risk factors
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
Braz. j. infect. dis
Journal subject:
Communicable Diseases
Year:
2014
Type:
Article
/
Project document
Affiliation country:
China
Institution/Affiliation country:
Xi'an Jiaotong University/CN
Similar
MEDLINE
...
LILACS
LIS